1.
121例N2-Ⅲa期NSCLC患者临床资料
Clinical characteristics of 121 patients with pathological N2-Ⅲa NSCLC
| Variables | Value | Percentage |
| ADC: adenocarcinoma; SQCC: squamous cell carcinoma; RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; LUL: left upper lobe; LLL: left lower lobe; MIL: minimally invasive lobectomy; NSCLC: non-small cell lung cancer. | ||
| Age (yr) | ||
| Median age | 58 | - |
| Age range | 37-78 | - |
| Gender | ||
| Male | 82 | 67.8% |
| Female | 39 | 32.2% |
| Smooking index | ||
| ≤400 | 77 | 63.6% |
| > 400 | 44 | 36.4% |
| Chemotherapy | 100 | 82.6% |
| Neoadjuvant chemotherapy | 40 | 33.1% |
| Adjuvant chemotherapy | 93 | 76.9% |
| Tumor location | ||
| RUL | 42 | 34.7% |
| RML | 8 | 6.6% |
| RLL | 28 | 23.1% |
| LUL | 29 | 24.0% |
| LLL | 14 | 11.6% |
| Surgical approach | ||
| MIL | 77 | 63.6% |
| Conventional thoracotomy | 44 | 36.4% |
| Operation mode | ||
| Lobectomy/Bilobectoy/Sleeve lobectomy | 117 | 96.7% |
| Pneumonectomy | 4 | 3.3% |
| pT stage | ||
| Ⅰ | 34 | 28.1% |
| Ⅱ | 76 | 62.8% |
| Ⅲ | 11 | 9.1% |
| Histological types | ||
| ADC | 88 | 72.7% |
| SQCC | 24 | 19.8% |
| Others | 9 | 7.4% |
| Intravascularcancer emboli grade (SQCC) | ||
| Yes | 38 | 31.4% |
| No | 83 | 68.6% |